Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
24 studies found for:    " December 05, 2007":" January 04, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 05, 2007":" January 04, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Motivational interviewing with cognitive behavioral therapy;   Behavioral: Modified directly observed therapy
2 Completed Family-Based HIV Prevention for Latinos
Condition: HIV Infections
Interventions: Behavioral: Family-Based HIV Prevention for Latinos;   Behavioral: General Health Promotion
3 Completed Role of Positive Affect in Adjustment to HIV
Condition: HIV Infections
Intervention:
4 Completed
Has Results
Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: buprenorphine;   Other: Clinical evaluations/Blood draws
5 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
6 Completed
Has Results
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Pegylated Interferon-alpha 2a, 180 mcg/week sc;   Drug: Pegylated Interferon-alpha 2a, 90 mcg/week sc
7 Completed HIV-HCV Coinfection: Impact of Immune Dysfunction
Conditions: HIV Infections;   Hepatitis
Intervention:
8 Unknown  Energy Specific Far Infrared Radiation Treatment for AIDS
Condition: HIV Infections
Intervention: Radiation: Far infrared
9 Completed
Has Results
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Biological: Cervarix TM;   Biological: Placebo Control
10 Completed CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS
Condition: HIV Infections
Intervention:
11 Completed Understanding the Increased Risk of Cardiovascular Disease in People With HIV
Condition: HIV Infections
Intervention: Drug: Antiretroviral Therapy (ART)
12 Completed Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
Conditions: HIV Infections;   Atherosclerosis
Intervention:
13 Withdrawn Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
14 Completed Relationship Between HIV-1 Subtype and ARV Response
Condition: HIV Infections
Intervention: Drug: NRTI/NNRTI/ Kaletra
15 Completed Family Access to Care Study (FACS)
Condition: HIV Infections
Intervention:
16 Completed Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Tenofovir gel placebo
17 Completed Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir gel
18 Completed HIV Resistance and Treatment Strategies
Condition: HIV Infections
Intervention:
19 Completed Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
20 Unknown  Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
Conditions: Tuberculosis;   HIV
Interventions: Procedure: Interferon-Gamma Release Assay;   Drug: RT-23

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years